Affimed
About:
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Website: https://www.affimed.com/
Twitter/X: affimed
Top Investors: OrbiMed, Roche, Novo Nordisk, Perceptive Advisors, Novo Holdings
Description:
At Affimed, they are committed to improving outcomes for patients with cancer. Their scientific team has been devoted to unlocking the power of the innate immune system for nearly two decades to provide a unqiue approach to fighting cancer. With their unparalleled expertise in innate immunity and innate cell engager-based medicines, they aim to overcome the limitations and challenges faced by current immuno-oncology (I-O) therapies.
$534M
$1M to $10M
Heidelberg, Baden-Wurttemberg, Germany
2000-01-01
info(AT)affimed.com
Melvyn Little
51-100
2022-04-13
Public
© 2025 bioDAO.ai